Market Place
Sourcing Support
All News #Library
Biotech
Neurosterix Advances NTX-253 For Schizophrenia Phase 1 Study
23 Apr 2026 //
GLOBENEWSWIRE
Addex Publishes Preclinical Data On mGlu7 NAMS For Anxiety
03 Feb 2026 //
GLOBENEWSWIRE
Neurosterix Launches Phase 1 Study of NTX-253 in Schizophrenia
07 Jan 2026 //
GLOBENEWSWIRE
Addex Therapeutics Reports Q3 2025 Results and Corporate Update
04 Dec 2025 //
GLOBENEWSWIRE
Addex Therapeutics To Release 2025 Half-Year Financials
26 Sep 2025 //
GLOBENEWSWIRE
Addex To Participate In H.C. Wainwright Conference
04 Sep 2024 //
GLOBENEWSWIRE
Addex to Present at the Swiss Biotech Day 2024
19 Apr 2024 //
GLOBENEWSWIRE
Addex to Present at Biotech Showcase„¢ 2024
05 Jan 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.